Director, Global Scientific Communications
As the Director, Global Scientific Communications, Dr. Benmaamar reviews, analyzes, and disseminates key scientific data that are critical to the success of the Foundation’s research and innovation programs, which are aimed at accelerating smoking cessation and harm reduction. She develops scientific communication strategies and ensures accurate scientific messaging.
Prior to joining the Foundation, Dr. Benmaamar was Manager of Global Publications and Scientific Communications, Oncology Business Group, at Eisai Pharmaceuticals. She managed the global communication of the results of clinical trials, and the review process of scientific and medical documents prior to their publication in peer-review journals and their presentation at scientific meetings.
Before working at Eisai, Dr. Benmaamar was Senior Researcher at New York University, Langone Medical Center, Radiation Oncology. She managed pancreatic cancer research. She helped design innovative research projects to better understand the various molecular, immunological, and metabolic aspects of pancreatic cancer. In earlier years, Dr. Benmaamar was Associate Director of Medical Communications at medical communication agencies, partnering with pharmaceuticals to develop scientific content for presentations at conferences and advisory boards, and for patient and healthcare provider websites.
In addition to her scientific experience, Dr. Benmaamar worked at the United Nations as a Conference Manager. She facilitated and coordinated a wide range of conferences such as those of the World Health Organization (WHO), United Nations Children’s Fund (UNICEF), Human Rights Committee, General Assembly, Indigenous Peoples’ Forum, and Conference of the Parties (COP 20) to the United Nations Framework Convention on Climate Change. She speaks four of the six United Nations official languages (English, French, Arabic, and Spanish), as well as Italian.
Dr. Benmaamar is a seasoned freelance writer for The Lancet Oncology, mainly communicating groundbreaking results of clinical trials on several types of cancer. She holds a PhD in Pharmacology from Univerisité Louis Pasteur, Strasbourg, France.
POSTS BY AUTHOR
Smoking is a major behavioral risk factor common to all four major noncommunicable diseases (NCDs)—namely, cardiovascular disease (CVD), cancer, diabetes, and chronic respiratory diseases. Approximately 80% of the world’s 1.1 billion smokers live in low- and middle-income countries (LMICs); and NCDs are estimated to cause more than two-thirds of all deaths in developing countries. This […]
Morven Summary (PDF) Participants of the Morven Dialogue that was held in November 2018 identified 10 Core Principles that aim to guide ongoing and future discussions for the development and implementation of effective policies and objectives on harm reduction. We outline the position of the Foundation for a Smoke-Free World (herein referred to as “The […]
Mission is to eliminate smoking worldwide by supporting cessation & harm reduction #research, and transitioning tobacco #farmers to alternative livelihoods.
In his latest blog, Derek Yach notes, “In 2020, we must not only acknowledge that smoking persists as a pressing global health threat, but also adapt our tactics to address the ways in which this threat has evolved.” #AccelerateTransformation http://bit.ly/37ci1ma
How insurers can profit while helping people to quit smoking
The Foundation is collaborating with the insurance industry to raise awareness about how insurers can help end smoking. This could create shared value that will benefit smokers, insurers and society as a whole. #endsmoking, #insuranceindustry. http://bit.ly/2sZCifK
David Janazzo, CFO and VP of #IndustryTransformation examines how Tobacco Free Portfolios, Bloomberg STOP’s Global Tobacco Industry Interference Index, and FSFW’s Tobacco Transformation Index are complementary. http://bit.ly/2QTQfoI
New ASH & Cancer Research UK report:
"Local authorities which do not currently provide e-cigarette starter packs as part of their cessation offer should consider doing so to give local smokers the best possible chance to quit."
"Only" 11% do so now.
Sign up with your email address to receive news and updates